Rubella overview: Difference between revisions
m (Bot: Removing from Primary care) |
|||
| (21 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Rubella}} | {{Rubella}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{AKI}} | ||
'''''Synonyms''''': German measles; 3 day measles | '''''Synonyms''''': German measles; 3 day measles | ||
==Overview== | ==Overview== | ||
Rubella is a common childhood infection usually with minimal systemic upset although transient [[arthropathy]] may occur in adults. Serious complications are very rare. If it were not for the effects of transplacental infection on the developing | [[Rubella]] is a common childhood infection usually with minimal systemic upset although transient [[arthropathy]] may occur in adults. Serious complications are very rare. If it were not for the effects of [[transplacental]] infection on the developing [[fetus]], rubella is a relatively trivial infection. | ||
==Historical Perspective== | ==Historical Perspective== | ||
The clinical picture resembling [[rubella]] was described for the first time in 1814 and its role in causing [[congenital anomalies]] was identified in 1942. The virus was isolated for the first time in 1962 by two independent groups in [[tissue culture]]. | |||
==Pathophysiology== | ==Pathophysiology== | ||
The pathophysiology of rubella is not completely understood. Viral replication in the respiratory epithelium occurs following transmission of the virus via contact with droplet secretions from an infected person. Viremia subsequently ensues, with the onset of the rubella rash occurring at the peak of viremia. | The [[pathophysiology]] of [[rubella]] is not completely understood. [[Viral]] [[replication]] in the [[respiratory epithelium]] occurs following transmission of the [[virus]] via contact with droplet secretions from an infected person. [[Viremia]] subsequently ensues, with the onset of the [[rubella]] [[rash]] occurring at the peak of [[viremia]]. | ||
==Causes== | ==Causes== | ||
The disease is caused by | The disease is caused by [[rubella virus]], a [[togavirus]] that is enveloped and has a single-stranded [[RNA]] genome.<ref name="pmid7817880">{{cite journal | ||
|author=Frey TK | |author=Frey TK | ||
|title=Molecular biology of rubella virus. | |title=Molecular biology of rubella virus. | ||
| Line 23: | Line 23: | ||
|pmid=7817880 | |pmid=7817880 | ||
|doi= | |doi= | ||
}}</ref> The virus is transmitted by the respiratory route and replicates in the [[nasopharynx]] and [[lymph nodes]]. The virus is found in the blood 5 to 7 days after infection and spreads throughout the body. It is capable of crossing the placenta and infecting the fetus | }}</ref> The [[virus]] is transmitted by the respiratory route and replicates in the [[nasopharynx]] and [[lymph nodes]]. The [[virus]] is found in the [[blood]] 5 to 7 days after infection and spreads throughout the body. It is capable of crossing the [[placenta]] and infecting the [[fetus]].<ref name="pmid16022642">{{cite journal | ||
|author=Edlich RF, Winters KL, Long WB, Gubler KD | |author=Edlich RF, Winters KL, Long WB, Gubler KD | ||
|title=Rubella and congenital rubella (German measles). | |title=Rubella and congenital rubella (German measles). | ||
| Line 35: | Line 35: | ||
|url=http://www.begellhouse.com/journals/1bef42082d7a0fdf,69622d0e4ea6cf4b,4fb4b32d494cf55c.html | |url=http://www.begellhouse.com/journals/1bef42082d7a0fdf,69622d0e4ea6cf4b,4fb4b32d494cf55c.html | ||
}}</ref> | }}</ref> | ||
==Differentiating Rubella from other Diseases== | ==Differentiating Rubella from other Diseases== | ||
Rubella infection must be differentiated from diseases presenting with features of skin rash, fever and lymphadenopathy such as measles, | [[Rubella]] infection must be differentiated from diseases presenting with features of [[Rash|skin rash]], [[fever]] and [[lymphadenopathy]] such as [[measles]], [[coxsackievirus]] infection and [[infectious mononucleosis]]. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
In the United States, endemic rubella virus transmission has been eliminated since 2001. From 2004 to 2013, 10 cases of rubella infection | In the United States, [[endemic]] [[rubella virus]] transmission has been eliminated since 2001. From 2004 to 2013, 10 cases of [[rubella]] infection were diagnosed in the immigrants. | ||
==Risk Factors== | ==Risk Factors== | ||
The [[Risk factor|risk factors]] predisposing for [[rubella]] infection include: contact with infected patient and not receiving [[Vaccination|immunization]] according to the standard schedule. | |||
==Screening== | ==Screening== | ||
There are no standard screening test recommended for [[rubella]] infection, however [[pregnant]] women with suspected [[rubella]] infection must be investigated to confirm the diagnosis to prevent fetal anomalies. | |||
==Natural History and Complications== | ==Natural History and Complications== | ||
[[Rubella]] is transmitted by direct contact and presents with a [[fever]], [[rash]] and [[lymphadenopathy]]. It is usually a self limiting infection and resolves without any complications. Few patients might develop complications such as [[arthritis]] which needs symptomatic treatment. The [[prognosis]] is good in adults with complete resolution of symptoms in a week. | |||
==Diagnosis== | ==Diagnosis== | ||
===History and Symptoms=== | ===History and Symptoms=== | ||
[[Patient|Patients]] with [[rubella]] infection present with a [[fever]], skin [[rash]] and [[cervical]] [[lymphadenopathy]]. [[Malaise]] and [[anorexia]] precede the development of [[fever]] and [[rash]]. | |||
===Physical Examination=== | ===Physical Examination=== | ||
[[Rubella]] infection in adults presents with low grade [[fever]] and a [[maculopapular]] [[rash]] starting on the [[face]] and spreads [[caudally]]. Cervical [[lymphadenopathy]] is present in majority of the patients. | |||
===Laboratory Diagnosis=== | ===Laboratory Diagnosis=== | ||
All patients with suspected [[rubella]] infection must be investigated further to confirm the diagnosis. [[Serological testing|Serological]] tests to look for the presence of [[rubella]] specific [[IgG]] [[antibodies]] and [[IgG]] [[avidity]] and [[RT-PCR]] should be done to confirm the diagnosis. | |||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | ===Medical Therapy=== | ||
There is | There is no specific [[antiviral]] [[therapy]] for [[rubella]] infection. Symptomatic therapy and reporting the infection to local disease control agencies is recommended. | ||
===Surgical Therapy=== | ===Surgical Therapy=== | ||
Surgical intervention is not recommended for the management of [[rubella]] infection. | |||
==Prevention== | ==Prevention== | ||
===Primary Prevention=== | ===Primary Prevention=== | ||
[[Rubella]] infections are prevented by active [[immunization]] programs using live, disabled [[virus]] [[vaccines]]. Two live attenuated virus [[vaccines]], RA 27/3 and Cendehill strains, are effective in the prevention of adult disease | |||
===Secondary Prevention=== | ===Secondary Prevention=== | ||
All the [[Patient|patients]] with confirmed [[rubella]] infection must be [[Vaccination|vaccinated]]. [[Pregnancy|Pregnant]] women should be [[Vaccination|vaccinated]] after delivery of the [[baby]].<ref name="pmid1115060">{{cite journal| author=Fleet WF, Vaughn W, Lefkowitz LB, Schaffner W, Federspiel CF| title=Gestational exposure to rubella vaccinees: a population surveillance study. | journal=Am J Epidemiol | year= 1975 | volume= 101 | issue= 3 | pages= 220-30 | pmid=1115060 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1115060 }} </ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Teratogens]] | [[Category:Teratogens]] | ||
| Line 78: | Line 76: | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Togaviruses]] | [[Category:Togaviruses]] | ||
[[Category:Emergency medicine]] | |||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category: | [[Category:Dermatology]] | ||
Latest revision as of 00:04, 30 July 2020
|
Rubella Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rubella overview On the Web |
|
American Roentgen Ray Society Images of Rubella overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]
Synonyms: German measles; 3 day measles
Overview
Rubella is a common childhood infection usually with minimal systemic upset although transient arthropathy may occur in adults. Serious complications are very rare. If it were not for the effects of transplacental infection on the developing fetus, rubella is a relatively trivial infection.
Historical Perspective
The clinical picture resembling rubella was described for the first time in 1814 and its role in causing congenital anomalies was identified in 1942. The virus was isolated for the first time in 1962 by two independent groups in tissue culture.
Pathophysiology
The pathophysiology of rubella is not completely understood. Viral replication in the respiratory epithelium occurs following transmission of the virus via contact with droplet secretions from an infected person. Viremia subsequently ensues, with the onset of the rubella rash occurring at the peak of viremia.
Causes
The disease is caused by rubella virus, a togavirus that is enveloped and has a single-stranded RNA genome.[1] The virus is transmitted by the respiratory route and replicates in the nasopharynx and lymph nodes. The virus is found in the blood 5 to 7 days after infection and spreads throughout the body. It is capable of crossing the placenta and infecting the fetus.[2]
Differentiating Rubella from other Diseases
Rubella infection must be differentiated from diseases presenting with features of skin rash, fever and lymphadenopathy such as measles, coxsackievirus infection and infectious mononucleosis.
Epidemiology and Demographics
In the United States, endemic rubella virus transmission has been eliminated since 2001. From 2004 to 2013, 10 cases of rubella infection were diagnosed in the immigrants.
Risk Factors
The risk factors predisposing for rubella infection include: contact with infected patient and not receiving immunization according to the standard schedule.
Screening
There are no standard screening test recommended for rubella infection, however pregnant women with suspected rubella infection must be investigated to confirm the diagnosis to prevent fetal anomalies.
Natural History and Complications
Rubella is transmitted by direct contact and presents with a fever, rash and lymphadenopathy. It is usually a self limiting infection and resolves without any complications. Few patients might develop complications such as arthritis which needs symptomatic treatment. The prognosis is good in adults with complete resolution of symptoms in a week.
Diagnosis
History and Symptoms
Patients with rubella infection present with a fever, skin rash and cervical lymphadenopathy. Malaise and anorexia precede the development of fever and rash.
Physical Examination
Rubella infection in adults presents with low grade fever and a maculopapular rash starting on the face and spreads caudally. Cervical lymphadenopathy is present in majority of the patients.
Laboratory Diagnosis
All patients with suspected rubella infection must be investigated further to confirm the diagnosis. Serological tests to look for the presence of rubella specific IgG antibodies and IgG avidity and RT-PCR should be done to confirm the diagnosis.
Treatment
Medical Therapy
There is no specific antiviral therapy for rubella infection. Symptomatic therapy and reporting the infection to local disease control agencies is recommended.
Surgical Therapy
Surgical intervention is not recommended for the management of rubella infection.
Prevention
Primary Prevention
Rubella infections are prevented by active immunization programs using live, disabled virus vaccines. Two live attenuated virus vaccines, RA 27/3 and Cendehill strains, are effective in the prevention of adult disease
Secondary Prevention
All the patients with confirmed rubella infection must be vaccinated. Pregnant women should be vaccinated after delivery of the baby.[3]
References
- ↑ Frey TK (1994). "Molecular biology of rubella virus". Adv. Virus Res. 44: 69–160. PMID 7817880.
- ↑ Edlich RF, Winters KL, Long WB, Gubler KD (2005). "Rubella and congenital rubella (German measles)". J Long Term Eff Med Implants. 15 (3): 319–28. PMID 16022642.
- ↑ Fleet WF, Vaughn W, Lefkowitz LB, Schaffner W, Federspiel CF (1975). "Gestational exposure to rubella vaccinees: a population surveillance study". Am J Epidemiol. 101 (3): 220–30. PMID 1115060.